Han Xue-Jie, Li Jian-Qiang, Khannanova Zulfiia, Li Yue
Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang 150001, China.
Bashkir State Medical University, Ufa, Republic Bashkortostan, Russia.
Chronic Dis Transl Med. 2020 Jan 14;5(4):221-233. doi: 10.1016/j.cdtm.2019.12.007. eCollection 2019 Dec.
Owing to early diagnosis and rapid development of treatments for cancers, the five-year survival rate of all cancer types has markedly improved worldwide. Over time, however, there has been an increase in the number of cancer patients who develop coronary artery disease (CAD) due to different causes. First, many risk factors are shared between cancer and CAD. Second, inflammation and oxidative stress are common underlying pathogeneses in both disorders. Lastly, cancer therapy can result in endothelial injury, coronary artery spasm, and coagulation, thereby increasing the risk of CAD. As more cancer patients are being diagnosed with CAD, specialized cardiac care should be established to minimize the cardiovascular mortality of cancer survivors.
由于癌症早期诊断及治疗方法的迅速发展,全球所有癌症类型的五年生存率已显著提高。然而,随着时间的推移,因不同原因患冠状动脉疾病(CAD)的癌症患者数量有所增加。首先,癌症和CAD有许多共同的危险因素。其次,炎症和氧化应激是这两种疾病常见的潜在发病机制。最后,癌症治疗可导致内皮损伤、冠状动脉痉挛和凝血,从而增加患CAD的风险。随着越来越多的癌症患者被诊断出患有CAD,应建立专门的心脏护理,以尽量降低癌症幸存者的心血管死亡率。